Annual ROE:
-414.62%-614.15%(-307.80%)Summary
- As of today, ALNY annual return on equity is -414.62%, with the most recent change of -614.15% (-307.80%) on December 31, 2024.
- During the last 3 years, ALNY annual ROE has fallen by -308.31% (-290.01%).
- ALNY annual ROE is now -307.80% below its all-time high of 199.53%, reached on December 31, 2023.
Performance
ALNY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-345.03%+164.30%(+32.26%)Summary
- As of today, ALNY quarterly return on equity is -345.03%, with the most recent change of +164.30% (+32.26%) on June 30, 2025.
- Over the past year, ALNY quarterly ROE has dropped by -392.95% (-820.01%).
- ALNY quarterly ROE is now -138.11% below its all-time high of 905.33%, reached on December 31, 2024.
Performance
ALNY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ALNY ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -307.8% | -820.0% |
| 3Y3 Years | -290.0% | -95.2% |
| 5Y5 Years | -541.2% | -515.9% |
ALNY ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -307.8% | +21.2% | -138.1% | +94.0% |
| 5Y | 5-Year | -307.8% | +21.2% | -138.1% | +94.0% |
| All-Time | All-Time | -307.8% | +21.2% | -138.1% | +94.0% |
ALNY ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -345.03%(+32.3%) |
| Mar 2025 | - | -509.33%(-156.3%) |
| Dec 2024 | -414.62%(-307.8%) | 905.33%(+179.7%) |
| Sep 2024 | - | 323.66%(+575.4%) |
| Jun 2024 | - | 47.92%(-63.4%) |
| Mar 2024 | - | 131.01%(-21.6%) |
| Dec 2023 | 199.53%(+137.9%) | 167.09%(-18.8%) |
| Sep 2023 | - | 205.70%(-56.8%) |
| Jun 2023 | - | 476.27%(+108.2%) |
| Mar 2023 | - | -5780.99%(-860.3%) |
| Dec 2022 | -526.14%(-394.9%) | -601.97%(-88.8%) |
| Sep 2022 | - | -318.86%(-80.4%) |
| Jun 2022 | - | -176.73%(-39.5%) |
| Mar 2022 | - | -126.66%(-23.0%) |
| Dec 2021 | -106.31%(-52.0%) | -103.00%(-17.2%) |
| Sep 2021 | - | -87.89%(-7.3%) |
| Jun 2021 | - | -81.94%(-10.5%) |
| Mar 2021 | - | -74.18%(-11.0%) |
| Dec 2020 | -69.92%(-8.1%) | -66.85%(-5.2%) |
| Sep 2020 | - | -63.54%(-13.4%) |
| Jun 2020 | - | -56.02%(+2.7%) |
| Mar 2020 | - | -57.56%(+0.6%) |
| Dec 2019 | -64.66%(-30.3%) | -57.90%(-8.4%) |
| Sep 2019 | - | -53.40%(+4.1%) |
| Jun 2019 | - | -55.69%(-7.0%) |
| Mar 2019 | - | -52.07%(-8.3%) |
| Dec 2018 | -49.63%(-35.8%) | -48.06%(-6.6%) |
| Sep 2018 | - | -45.08%(-15.9%) |
| Jun 2018 | - | -38.91%(+3.1%) |
| Mar 2018 | - | -40.16%(+6.7%) |
| Dec 2017 | -36.54%(+2.7%) | -43.06%(+7.7%) |
| Sep 2017 | - | -46.64%(-5.1%) |
| Jun 2017 | - | -44.38%(-8.2%) |
| Mar 2017 | - | -41.00%(-9.7%) |
| Dec 2016 | -37.54%(-42.4%) | -37.37%(-13.5%) |
| Sep 2016 | - | -32.93%(-14.7%) |
| Jun 2016 | - | -28.70%(-12.0%) |
| Mar 2016 | - | -25.62%(-13.6%) |
| Dec 2015 | -26.36%(+55.9%) | -22.56%(-24.0%) |
| Sep 2015 | - | -18.19%(-10.1%) |
| Jun 2015 | - | -16.52%(-7.9%) |
| Mar 2015 | - | -15.31%(+65.9%) |
| Dec 2014 | -59.74% | -44.96%(+18.4%) |
| Sep 2014 | - | -55.10%(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | -64.37%(+16.7%) |
| Mar 2014 | - | -77.28%(-129.0%) |
| Dec 2013 | -44.13%(+47.5%) | -33.75%(+30.3%) |
| Sep 2013 | - | -48.45%(+0.4%) |
| Jun 2013 | - | -48.64%(+5.4%) |
| Mar 2013 | - | -51.40%(+21.0%) |
| Dec 2012 | -84.12%(-101.5%) | -65.05%(-81.0%) |
| Sep 2012 | - | -35.94%(-6.5%) |
| Jun 2012 | - | -33.76%(+7.1%) |
| Mar 2012 | - | -36.35%(+13.5%) |
| Dec 2011 | -41.74%(-61.2%) | -42.00%(-21.8%) |
| Sep 2011 | - | -34.49%(-13.3%) |
| Jun 2011 | - | -30.44%(-2.8%) |
| Mar 2011 | - | -29.61%(-13.5%) |
| Dec 2010 | -25.89%(-3.4%) | -26.08%(-0.9%) |
| Sep 2010 | - | -25.86%(-3.8%) |
| Jun 2010 | - | -24.92%(+12.3%) |
| Mar 2010 | - | -28.43%(-13.0%) |
| Dec 2009 | -25.04%(-91.4%) | -25.17%(+0.6%) |
| Sep 2009 | - | -25.31%(-16.9%) |
| Jun 2009 | - | -21.66%(-32.6%) |
| Mar 2009 | - | -16.33%(-25.4%) |
| Dec 2008 | -13.08%(+69.4%) | -13.02%(-71.1%) |
| Sep 2008 | - | -7.61%(+77.3%) |
| Jun 2008 | - | -33.46%(+0.8%) |
| Mar 2008 | - | -33.74%(+24.0%) |
| Dec 2007 | -42.70%(-62.2%) | -44.39%(+19.3%) |
| Sep 2007 | - | -55.04%(-72.3%) |
| Jun 2007 | - | -31.94%(+2.4%) |
| Mar 2007 | - | -32.73%(-12.7%) |
| Dec 2006 | -26.32%(+66.9%) | -29.05%(+40.3%) |
| Sep 2006 | - | -48.68%(+24.2%) |
| Jun 2006 | - | -64.19%(+22.7%) |
| Mar 2006 | - | -83.05%(+22.5%) |
| Dec 2005 | -79.53%(-12.4%) | -107.17%(-15.2%) |
| Sep 2005 | - | -93.02%(-31.5%) |
| Jun 2005 | - | -70.76%(-12.2%) |
| Mar 2005 | - | -63.09%(+24.4%) |
| Dec 2004 | -70.78%(+14.8%) | -83.42%(+81.2%) |
| Sep 2004 | - | -444.77%(-114.6%) |
| Jun 2004 | - | -207.29%(+96.4%) |
| Mar 2004 | - | -5754.41%(-8681.0%) |
| Dec 2003 | -83.11%(-170.0%) | 67.06% |
| Dec 2002 | -30.78% | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual return on equity?
- What is the all-time high annual ROE for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of ALNY is -414.62%
What is the all-time high annual ROE for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual return on equity is 199.53%
What is Alnylam Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, ALNY annual return on equity has changed by -614.15% (-307.80%)
What is Alnylam Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of ALNY is -345.03%
What is the all-time high quarterly ROE for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly return on equity is 905.33%
What is Alnylam Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, ALNY quarterly return on equity has changed by -392.95% (-820.01%)